717 related articles for article (PubMed ID: 20966421)
1. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.
Furie KL; Kasner SE; Adams RJ; Albers GW; Bush RL; Fagan SC; Halperin JL; Johnston SC; Katzan I; Kernan WN; Mitchell PH; Ovbiagele B; Palesch YY; Sacco RL; Schwamm LH; Wassertheil-Smoller S; Turan TN; Wentworth D;
Stroke; 2011 Jan; 42(1):227-76. PubMed ID: 20966421
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.
Sacco RL; Adams R; Albers G; Alberts MJ; Benavente O; Furie K; Goldstein LB; Gorelick P; Halperin J; Harbaugh R; Johnston SC; Katzan I; Kelly-Hayes M; Kenton EJ; Marks M; Schwamm LH; Tomsick T; ; ;
Circulation; 2006 Mar; 113(10):e409-49. PubMed ID: 16534023
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
Kernan WN; Ovbiagele B; Black HR; Bravata DM; Chimowitz MI; Ezekowitz MD; Fang MC; Fisher M; Furie KL; Heck DV; Johnston SC; Kasner SE; Kittner SJ; Mitchell PH; Rich MW; Richardson D; Schwamm LH; Wilson JA;
Stroke; 2014 Jul; 45(7):2160-236. PubMed ID: 24788967
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.
Sacco RL; Adams R; Albers G; Alberts MJ; Benavente O; Furie K; Goldstein LB; Gorelick P; Halperin J; Harbaugh R; Johnston SC; Katzan I; Kelly-Hayes M; Kenton EJ; Marks M; Schwamm LH; Tomsick T; ; ; ;
Stroke; 2006 Feb; 37(2):577-617. PubMed ID: 16432246
[TBL] [Abstract][Full Text] [Related]
5. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale.
Patti G; Pelliccia F; Gaudio C; Greco C
Am J Cardiol; 2015 Mar; 115(6):837-43. PubMed ID: 25620037
[TBL] [Abstract][Full Text] [Related]
7. Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt.
Weimar C; Holle DN; Benemann J; Schmid E; Schminke U; Haberl RL; Diener HC; Goertler M;
Cerebrovasc Dis; 2009; 28(4):349-56. PubMed ID: 19628936
[TBL] [Abstract][Full Text] [Related]
8. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
Wahl A; Jüni P; Mono ML; Kalesan B; Praz F; Geister L; Räber L; Nedeltchev K; Mattle HP; Windecker S; Meier B
Circulation; 2012 Feb; 125(6):803-12. PubMed ID: 22238228
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
Meschia JF; Bushnell C; Boden-Albala B; Braun LT; Bravata DM; Chaturvedi S; Creager MA; Eckel RH; Elkind MS; Fornage M; Goldstein LB; Greenberg SM; Horvath SE; Iadecola C; Jauch EC; Moore WS; Wilson JA; ; ; ; ;
Stroke; 2014 Dec; 45(12):3754-832. PubMed ID: 25355838
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
Calvet D; Bracard S; Mas JL;
Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
[TBL] [Abstract][Full Text] [Related]
11. 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack.
Wang Y; Liu M; Pu C
Int J Stroke; 2017 Apr; 12(3):302-320. PubMed ID: 28381199
[TBL] [Abstract][Full Text] [Related]
12. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
13. Stroke subtypes and interventional studies for transient ischemic attack.
Lavallée P; Amarenco P
Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
[TBL] [Abstract][Full Text] [Related]
15. Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke.
Kaplan ED; Sacco RL
Curr Neurol Neurosci Rep; 2002 Jan; 2(1):31-7. PubMed ID: 11898580
[TBL] [Abstract][Full Text] [Related]
16. Patent foramen ovale and cryptogenic stroke: a complex neuro-cardio-vascular problem.
Spies C; Wong M
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1455-67. PubMed ID: 19900028
[TBL] [Abstract][Full Text] [Related]
17. Letter by Borja and Garcia-Rafanell regarding article, "Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association".
Borja J; García-Rafanell J
Stroke; 2011 Jun; 42(6):e388; author reply e386. PubMed ID: 21546474
[No Abstract] [Full Text] [Related]
18. Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.
Mirzaali M; Dooley M; Wynne D; Cooter N; Lee L; Haworth P; Saha R; Gainsborough N; Hildick-Smith D
Catheter Cardiovasc Interv; 2015 Nov; 86(6):1078-84. PubMed ID: 26105198
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
Pineda AM; Nascimento FO; Yang SC; Kirtane AJ; Sommer RJ; Beohar N
Catheter Cardiovasc Interv; 2013 Nov; 82(6):968-75. PubMed ID: 23832613
[TBL] [Abstract][Full Text] [Related]
20. New aspects of paradoxical embolism.
Lehmeyer S; Lindhoff-Last E
Vasa; 2011 Jan; 40(1):31-40. PubMed ID: 21283971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
